Karachi: The Searle Company Limited has announced its financial results for the first quarter ending March 31, 2025, revealing no cash dividends, bonus shares, or rights shares for the period. The decision was approved during a Board of Directors meeting held on April 30, 2025, in Karachi.

The company's financial statement highlights the absence of entitlements or corporate actions, and no price-sensitive information was disclosed for the quarter. This marks a steady approach as the company navigates its financial strategies for the current fiscal year.

According to information available from the Pakistan Stock Exchange (PSX), The Searle Company Limited did not propose any dividends or bonus shares, reflecting a cautious fiscal policy in the early months of 2025. Additionally, no right shares were issued, and no other entitlements or corporate actions were announced.

The quarterly report, both unconsolidated and consolidated, has been prepared and will be transmitted through the Pakistan Unified Corporate Action Reporting System (PUCARS) separately, adhering to the established timeline for disclosures. The company is listed within the designated market category of the pharmaceutical sector.

These financial statements provide a clear view of the company's strategic direction and its current financial posture, as it refrains from distributing dividends and other shareholder incentives in the first quarter of 2025.